Home / Choriogonadotropin Alfa / Ireland
IE ATC G03GA08 · updated 2 Nov 2026
Choriogonadotropin Alfa shortage in Ireland
Is there a Choriogonadotropin Alfa shortage in Ireland?
Yes. As of 2 Nov 2026, 1 Choriogonadotropin Alfa product is reported short in Ireland, the first since 14 Oct 2026. The company estimate for the return is 6 Nov 2026. Main reason: increased demand.
Also short in Canada, Japan, Australia. All countries.
Affected products in Ireland
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IE | Ovitrelle 250 micrograms solution for injection in pre-filled pen | Merck Europe B.V. | 14 Oct 2026 | 6 Nov 2026 | Increased demand Unexpected increased demand |
Source
HPRA (Health Products Regulatory Authority). Official list. Shortages notified to the HPRA by marketing-authorisation holders; one row per pack.